“It all begins with an idea; transform medicine, make a difference. In the operating room, as an anesthesiologist, my role was important and personal and I hope that I had a positive impact on my patients’ lives. In venture capital and healthcare innovation, the scale of the potential impact is orders of magnitude greater than my impact as a clinician. Ultimately, the idea that drives me is that we can help so many souls with our work.”
Orrin Ailloni-Charas, MD, MBA
Co-Founder and Managing Partner, Cura Capital
Major advances in digital health, artificial intelligence, and genomics, combined with favorable government policy and social awareness allows us to chart a course to help transform healthcare for future generations.
We support the scientists, clinicians, and innovators, whose goals are to transform healthcare, with strategic deployment of capital, and by leveraging our deep technical, operational, and clinical expertise to find and guide the best startups to their exits. In this Era of Impact Investing, we target the parallel goals of having the greatest impact on the most souls and driving outsized long-term performance.
Orrin Ailloni-Charas, MD, MBA, is the Co-Founder and Managing Partner of Cura Capital. He has held many roles over the years, including anesthesiologist, venture fund manager, board member, CFO, CEO, entrepreneur, angel investor, and network builder. His experiences in these areas have provided Orrin a master class in early-stage healthcare investing. He brings his passion to help people as a doctor to his venture journey, fueling the desire to transform healthcare at scale and improve global health and well being.
